Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christopher Sumey & Thomas W Flaig. (2011) Adjuvant medical therapy for prostate cancer. Expert Opinion on Pharmacotherapy 12:1, pages 73-84.
Read now
Read now
Shandra Wilson. (2009) Update on the management of prostate cancer with goserelin acetate: patient perspectives. Cancer Management and Research 1, pages 99-105.
Read now
Read now
Articles from other publishers (22)
Niraj Kumar, Vibha Vasudeva, Siddharth Yadav, Vishnu Prasad & Samarth Patel. (2022) The impact of androgen deprivation therapy on the lipid profile in patients with prostate carcinoma. African Journal of Urology 28:1.
Crossref
Crossref
Benjamin Hawthorne, Kaleb Lund, Sydney Freggiaro, Risa Kaga & Jing Meng. (2022) The mechanism of the cytotoxic effect of Panax notoginseng extracts on prostate cancer cells. Biomedicine & Pharmacotherapy 149, pages 112887.
Crossref
Crossref
Mehmet Çağlar Çakıcı, Bülent Can, Özgür Kazan, Özgür Efiloğlu, Furkan Şendoğan, Taha Uçar, Turgay Turan & Asıf Yıldırım. (2022) Effects of androgen deprivation therapy on metabolic markers and bioelectrical impedance analyze in prostate cancer patients. Revista Internacional de Andrología 20:2, pages 96-101.
Crossref
Crossref
D Hough, JE Robinson, M Bellingham, LM Fleming, M McLaughlin, K Jama, IRH Haraldsen, AK Solbakk & NP Evans. (2019) Peripubertal GnRH and testosterone co-treatment leads to increased familiarity preferences in male sheep. Psychoneuroendocrinology 108, pages 70-77.
Crossref
Crossref
Linda Trinh, Kelly Arbour-Nicitopoulos, Catherine Sabiston,
Shabbir Alibhai, Jennifer Jones, Scott Berry, Andrew Loblaw & Guy Faulkner. (2015) A Qualitative Study Exploring the Perceptions
of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy. Oncology Nursing Forum 42:4, pages 398-406.
Crossref
Crossref
See Min ChoiSung Chul Kam. (2015) Metabolic effects of androgen deprivation therapy. Korean Journal of Urology 56:1, pages 12.
Crossref
Crossref
Elaine T. Lam & L. Michael Glodé. 2015. Urological Oncology. Urological Oncology
807
816
.
Lauren M. Walker, Susan Tran & John W. Robinson. (2013) Luteinizing Hormone–Releasing Hormone Agonists: A Quick Reference for Prevalence Rates of Potential Adverse Effects. Clinical Genitourinary Cancer 11:4, pages 375-384.
Crossref
Crossref
Josée Savard, Séverine Hervouet & Hans Ivers. (2012) Prostate cancer treatments and their side effects are associated with increased insomnia. Psycho-Oncology 22:6, pages 1381-1388.
Crossref
Crossref
Naveed H. Akhtar, Elan S. Diamond, Nicole Eiseler & Scott T. Tagawa. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective
889
900
.
John D. Bowman, Hyunah Kim & Juan J. Bustamante. (2012) Drug‐Induced Gynecomastia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:12, pages 1123-1140.
Crossref
Crossref
Elizabeth R. Kessler & Thomas W. Flaig. (2012) Optimal Management of Recurrent Prostate Cancer in Older Patients. Drugs & Aging 29:11, pages 871-883.
Crossref
Crossref
Tony Soeyonggo, Padraig Warde, Neil Fleshner, Narhari Timilshina & Shabbir M.H. Alibhai. (2012) Information needs of men on androgen deprivation therapy. BJU International 109:10, pages 1503-1509.
Crossref
Crossref
Katrien Vandecasteele, Piet Ost, Willem Oosterlinck, Valérie Fonteyne, Wilfried De Neve & Gert De Meerleer. (2011)
Evaluation of the Efficacy and Safety of
Salvia officinalis
in Controlling Hot Flashes in Prostate Cancer Patients Treated with Androgen Deprivation
. Phytotherapy Research 26:2, pages 208-213.
Crossref
Crossref
Xiaoyu Hou & Thomas W. Flaig. (2012) Redefining Hormone Sensitive Disease in Advanced Prostate Cancer. Advances in Urology 2012, pages 1-6.
Crossref
Crossref
Kristene Myklak & Shandra Wilson. (2011) An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer. Prostate Cancer 2011, pages 1-8.
Crossref
Crossref
Joanna Beate Korda & Frank Sommer. (2010) Die antiandrogene Therapie aus urologischer SichtAnti-androgen treatment of paraphilias from the urologist’s perspective. Forensische Psychiatrie, Psychologie, Kriminologie 4:S1, pages 17-21.
Crossref
Crossref
Stacy Elliott, David M. Latini, Lauren M. Walker, Richard Wassersug, John W. Robinson & ADT Survivorship Working Group. (2010) Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life. The Journal of Sexual Medicine 7:9, pages 2996-3010.
Crossref
Crossref
Howard S Kim & Stephen J Freedland. (2010) Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management. Current Opinion in Supportive & Palliative Care 4:3, pages 147-152.
Crossref
Crossref
JACQUELINE T. ENG, QUANCHAO ZHANG & HONG ZHU. (2010) Skeletal effects of castration on two eunuchs of Ming China. Anthropological Science 118:2, pages 107-116.
Crossref
Crossref
S J Freedland, J Eastham & N Shore. (2009) Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer. Prostate Cancer and Prostatic Diseases 12:4, pages 333-338.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:5.
Crossref
Crossref